Key result
Open surgical bailout after TAVR occurs in 1%-3% of cases, while prosthetic valve endocarditis occurs in ~5% within 5 years and increases mortality 3-fold.
Answers are grounded in this paper and cite their sources.
Aortic valve replacement, whether open or percutaneous, carries early and late complication risks, including structural valve deterioration and endocarditis.
Associate Editor's Introduction—Aortic valve replacement, whether performed open or percutaneously, inherently trades the native valve disease for a new disease by virtue of the prosthetic valve. Both approaches have pitfalls and complications early, from the procedure itself (eg, heart block, perivalvular leak, ventricular injury, coronary artery ostial impingement), and later (eg, prosthetic valve endocarditis, structural valve deterioration [SVD]). With transcatheter aortic valve replacement (TAVR), even after successful deployment, the biological nature of the valve implies that SVD will eventually occur, and the risks of thrombosis and prosthetic valve endocarditis remain.
No takes yet. Share an insight, caveat, or question.
Burke et al. (2021) conducted a review in Aortic valve disease requiring surgical reintervention after transcatheter aortic valve replacement (TAVR). Open surgical intervention / TAVR explantation was evaluated. Open surgical bailout after TAVR occurs in 1%-3% of cases, while prosthetic valve endocarditis occurs in ~5% within 5 years and increases mortality 3-fold.
Synapse has enriched 10 related papers. Consider them for comparative context: